Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1

Biochemical and Biophysical Research Communications

Volumn 485, Issue 2, 2017, Pages 380-387

  Fujiwara, Tohru ^a   Sasaki, Katsuyuki ^a,b   Saito, Kei ^a   Hatta, Shunsuke ^a   Ichikawa, Satoshi ^a   Kobayashi, Masahiro ^a   Okitsu, Yoko ^a   Fukuhara, Noriko ^a   Onishi, Yasushi ^a   Harigae, Hideo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Erythroid differentiation; FOG1; GATA 1; Histone modification; PU.1; Transcription factor

Indexed keywords

DNA; FRIEND OF GATA 1 PROTEIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN GAMMA CHAIN; HISTONE H3; LYSINE; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CHROMATIN; ERYTHROCYTE BAND 3 PROTEIN; GATA1 PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN SPI-1; SLC4A1 PROTEIN, HUMAN; TAL1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; ZFPM1 PROTEIN, HUMAN;

ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; ENHANCER REGION; ERYTHROLEUKEMIA CELL; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE LOCUS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; TRANSLATION INITIATION; VECTOR CONTROL; WESTERN BLOTTING; ACETYLATION; CELL LINE; ERYTHROLEUKEMIA; GENE EXPRESSION REGULATION; GENETICS; K-562 CELL LINE; METABOLISM; PATHOLOGY; RNA INTERFERENCE;

ACETYLATION; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL LINE; CHROMATIN; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, LEUKEMIC; HISTONES; HUMANS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYSINE; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 85013667249     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.02.068     Document Type: Article

References (29)

1. [1] Fujiwara, T., O'Geen, H., Keles, S., et al. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell. 36 (2009), 667–681.
2. [2] Yu, M., Riva, L., Xie, H., et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol. Cell. 36 (2009), 682–695.
3. [3] Soler, E., Andrieu-Soler, C., de Boer, E., et al. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes. Dev. 24 (2010), 277–289.
4. [4] Bresnick, E.H., Lee, H.Y., Fujiwara, T., et al. GATA switches as developmental drivers. J. Biol. Chem. 285 (2010), 31087–31093.
5. [5] Lahlil, R., Lécuyer, E., Herblot, S., et al. SCL assembles a multifactorial complex that determines glycophorin A expression. Mol. Cell. Biol. 24 (2004), 1439–1452.
6. [6] Wadman, I.A., Osada, H., Grütz, G.G., et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO. J. 16 (1997), 3145–3157.
7. [7] Fujiwara, T., Alqadi, Y.W., Okitsu, Y., et al. Role of transcriptional corepressor ETO2 in erythroid cells. Exp. Hematol. 41 (2013), 303–315.
8. [8] Fujiwara, T., Lee, H.Y., Sanalkumar, R., et al. Building multifunctionality into a complex containing master regulators of hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 20429–20434.
9. [9] Tsang, A.P., Visvader, J.E., Turner, C.A., et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90 (1997), 109–119.
10. [10] Pal, S., Cantor, A.B., Johnson, K.D., et al. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 980–985.
11. [11] Lee, H.Y., Johnson, K.D., Fujiwara, T., et al. Controlling hematopoiesis through sumoylation-dependent regulation of a GATA factor. Mol. Cell. 36 (2009), 984–995.
12. [12] Kim, S.I., Bresnick, E.H., Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene 26 (2007), 6777–6794.
13. [13] Saito, Y., Fujiwara, T., Ohashi, K., et al. High-throughput siRNA screening to reveal GATA-2 upstream transcriptional mechanisms in hematopoietic cells. PLoS One, 10, 2015, e0137079.
14. [14] Tsai, F.Y., Keller, G., Kuo, F.C., et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371 (1994), 221–226.
15. [15] Scott, E.W., Simon, M.C., Anastasi, J., et al. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994), 1573–1577.
16. [16] Tripic, T., Deng, W., Cheng, Y., et al. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113 (2009), 2191–2201.
17. [17] Miccio, A., Wang, Y., Hong, W., et al. NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO. J. 29 (2010), 442–456.
18. [18] Evans, T., Reitman, M., Felsenfeld, G., An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), 5976–5980.
19. [19] Merika, M., Orkin, S.H., DNA-binding specificity of GATA family transcription factors. Mol. Cell. Biol. 13 (1993), 3999–4010.
20. [20] Hsu, A.P., Johnson, K.D., Falcone, E.L., et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 121 (2013), 3830–3837.
21. [21] Denslow, S.A., Wade, P.A., The human Mi-2/NuRD complex and gene regulation. Oncogene 26 (2007), 5433–5438.
22. [22] Allen, H.F., Wade, P.A., Kutateladze, T.G., The NuRD architecture. Cell. Mol. Life. Sci. 70 (2013), 3513–3524.
23. [23] Nishibuchi, G., Shibata, Y., Hayakawa, T., et al. Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex. J. Biol. Chem. 289 (2014), 28956–28970.
24. [24] Kerenyi, M.A., Orkin, S.H., Networking erythropoiesis. J. Exp. Med. 207 (2010), 2537–2541.
25. [25] Amann, J.M., Nip, J., Strom, D.K., et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21 (2001), 6470–6483.
26. [26] Hoppe, P.S., Schwarzfischer, M., Loeffler, D., et al. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios. Nature 535 (2016), 299–302.
27. [27] Mancini, E., Sanjuan-Pla, A., Luciani, L., et al. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO. J. 31 (2012), 351–365.
28. [28] Nichols, K.E., Crispino, J.D., Poncz, M., et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat. Genet. 24 (2000), 266–270.
29. [29] Freson, K., Devriendt, K., Matthijs, G., et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 98 (2001), 85–92.